Your browser doesn't support javascript.
loading
Isolation, Structure Elucidation, and (Bio)Synthesis of Haprolid, a Cell-Type-Specific Myxobacterial Cytotoxin.
Steinmetz, Heinrich; Li, Jun; Fu, Chengzhang; Zaburannyi, Nestor; Kunze, Birgitte; Harmrolfs, Kirsten; Schmitt, Viktoria; Herrmann, Jennifer; Reichenbach, Hans; Höfle, Gerhard; Kalesse, Markus; Müller, Rolf.
Afiliação
  • Steinmetz H; Helmholtz Center for Infection Research (HZI), Department Microbial Drugs, Inhoffenstrasse 7, 38124, Braunschweig, Germany.
  • Li J; Institute for Organic Chemistry, Gottfried Leibniz Universität Hannover.
  • Fu C; Centre of Biomolecular Drug Research (BMWZ), Schneiderberg 1B, 30167, Hannover, Germany.
  • Zaburannyi N; Helmholtz Center for Infection Research (HZI), Inhoffenstrasse 7, 38124, Braunschweig, Germany.
  • Kunze B; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research and Pharmaceutical Biotechnology, Saarland University, Campus Building E8.1, 66123, Saarbrücken, Germany.
  • Harmrolfs K; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research and Pharmaceutical Biotechnology, Saarland University, Campus Building E8.1, 66123, Saarbrücken, Germany.
  • Schmitt V; Helmholtz Center for Infection Research (HZI), Department Microbial Drugs, Inhoffenstrasse 7, 38124, Braunschweig, Germany.
  • Herrmann J; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research and Pharmaceutical Biotechnology, Saarland University, Campus Building E8.1, 66123, Saarbrücken, Germany.
  • Reichenbach H; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research and Pharmaceutical Biotechnology, Saarland University, Campus Building E8.1, 66123, Saarbrücken, Germany.
  • Höfle G; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research and Pharmaceutical Biotechnology, Saarland University, Campus Building E8.1, 66123, Saarbrücken, Germany.
  • Kalesse M; Helmholtz Center for Infection Research (HZI), Inhoffenstrasse 7, 38124, Braunschweig, Germany.
  • Müller R; Helmholtz Center for Infection Research (HZI), Inhoffenstrasse 7, 38124, Braunschweig, Germany.
Angew Chem Int Ed Engl ; 55(34): 10113-7, 2016 08 16.
Article em En | MEDLINE | ID: mdl-27404448
ABSTRACT
Myxobacteria are well-established sources for novel natural products exhibiting intriguing bioactivities. We here report on haprolid (1) isolated from Byssovorax cruenta Har1. The compound exhibits an unprecedented macrolactone comprising four modified amino acids and a polyketide fragment. As configurational assignment proved difficult, a bioinformatic analysis of the biosynthetic gene cluster was chosen to predict the configuration of each stereocenter. In-depth analysis of the corresponding biosynthetic proteins established a hybrid polyketide synthase/nonribosomal peptide synthetase origin of haprolid and allowed for stereochemical assignments. A subsequent total synthesis yielded haprolid and corroborated all predictions made. Intriguingly, haprolid showed cytotoxicity against several cell lines in the nanomolar range whereas other cells were almost unaffected by treatment with the compound.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Myxococcales / Macrolídeos / Citotoxinas / Lactonas Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Myxococcales / Macrolídeos / Citotoxinas / Lactonas Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article